Navigation Links
Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
Date:6/29/2009

we need to achieve profitability. Our growing customer base, centred on leading companies developing new antibody and protein therapeutics, provides us with a strong platform to build Gyros into a successful, profitable business. We are now in a position to invest in the increased commercial resources needed to market the key advantages of our unique Gyrolab systems to both existing and new customers as we seek to drive our top-line growth."

Gyrolab is a versatile, automated analytical platform that dramatically reduces the time required to optimize and execute immunoassays. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. Applications span the entire spectrum for immunoassays and Gyrolab is now firmly established as the preferred solution for pharmacokinetic (PK) assays in the development of therapeutic proteins.

Per Carendi, CEO of SLS Invest, said, "We are very happy to have this opportunity to invest in Gyros. Erik and his management team have mapped out an exciting future for Gyros based on the real benefits that the Company's systems can deliver to developers of novel biotherapeutics. Given that biotherapeutics products are expected to play a significant role in the growth of the pharmaceutical industry as they are used in the treatment of an ever-increasing range of diseases, we are confident of Gyros' future success."

Notes to Editors:

About Gyros AB

Gyros is the world leader in automated micro-immunoassays for therapeutic protein development.

Gyrolab(R), the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. T
'/>"/>

SOURCE Gyros AB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pearl Therapeutics Raises $15.5 Million in Private Financing
2. Enobia Pharma Raises $40.1 Million Series B Financing
3. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
4. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
5. VisEn Medical Raises $7 Million in Series B Financing
6. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
9. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
10. Anesiva Raises $45 Million in Common Stock Offering
11. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology ... announced that it will be presenting at CALBIO 2015 ... nd at 3pm PST. Patrick Lucy, chief business officer ... current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and The ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6
... Faster. , ... Des Moines, Iowa (Vocus) November 6, 2008 -– DuPont ... Hermiston, Ore. The expansion is one of many steps DuPont business ... for Pioneer® brand products and help farmers meet the strong global demand ...
... Calif., Nov. 6 Frost & Sullivan ... of the Year Award in,molecular/cellular imaging has ... molecular platform for the targeting and imaging ... known as Aposense(R), is,an innovative set of ...
... 6 Morria Biopharmaceuticals,Plc, a biopharmaceutical company focused ... its ICH compliant Phase II equivalent,multi-center study of ... was given as an intranasal spray formulation., ... in allergic,rhinitis patients outside of the local allergy ...
Cached Biology Technology:DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain 2DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain 3Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 2Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 3Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 4Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 2Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 3
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
(Date:2/5/2015)... FRANCISCO , January 28, 2015 ... Market Analysis, Size And Segment Forecasts To 2020 has ... global IR camera market is expected to reach USD ... by Grand View Research, Inc. IR cameras help identify ... and are expected to witness surging demand in medical ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... , DEARBORN, Mich., Dec. 30 , ... project that explores automotive technology solutions to reduce driver stress ... aid overall human wellness Lincoln MKS to serve as test ... that could aid in reducing stress behind the wheel , ...
... new study has found that chlorophyll and its derivative chlorophyllin ... Aflatoxin is produced by a fungus that is a contaminant ... to cause liver cancer and can work in concert ... aflatoxin are carefully regulated in the United States, but are ...
... sight of a cockroach scurrying for cover may be nauseating, ... and is providing researchers at Oregon State University with what ... first legged robot that is capable of running effortlessly over ... their success to what,s being learned from these insects and ...
Cached Biology News:Ford and MIT Team Up To Improve Safety by Reducing Driver Stress 2Ford and MIT Team Up To Improve Safety by Reducing Driver Stress 3Ford and MIT Team Up To Improve Safety by Reducing Driver Stress 4Ford and MIT Team Up To Improve Safety by Reducing Driver Stress 5Chlorophylls effective against aflatoxin 2Chlorophylls effective against aflatoxin 3Cockroaches offer inspiration for running robots 2
Request Info...
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Request Info...
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
Biology Products: